Impax at a Glance

Welcome to our Media Center

Our Mission - To be a leader in the development, manufacturing and marketing of generic and branded pharmaceuticals utilizing our formulation expertise and unique drug delivery technologies, focusing on opportunities that increase shareholder value and provide long-term profitable growth.

Corporate Fact Sheet

  • Founded – Impax Laboratories was formed in December 1999 through the merger of publicly traded Global Pharmaceuticals and privately held Impax Pharmaceuticals.
  • Headquarters – Hayward, CA
  • Chairman – Robert R. Burr
  • President & CEO – G. Frederick Wilkinson
  • Employees – Approximately 1,000
  • 2014 Revenue - $596 million
  • Approved ANDAs (Abbreviated New Drug Applications) – 66
  • Stock exchange listing – Nasdaq: IPXL

Primary Businesses

Impax Generics
Impax Specialty Pharma

Media Contact

Mark Donohue
Vice President
Investor Relations and Corporate Communications
602 Office Center Drive, Suite 200
Fort Washington, PA 19034